A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma.
Aristea-Maria PapanotaPanagiotis TsiakanikasChristos K KontosPanagiotis MalandrakisChristine-Ivy LiacosIoannis Ntanasis-StathopoulosNikolaos KanelliasMaria GavriatopoulouEfstathios KastritisMargaritis AvgerisMeletios- Athanasios DimopoulosAndreas ScorilasEvangelos TerposPublished in: Cancers (2021)
Our study proposes a miRNA signature to facilitate MMBD diagnosis, especially in ambiguous cases. Moreover, we provide evidence of the prognostic role of let-7b-5p and miR-335-5p as non-invasive prognostic biomarkers in MM.